ArticleCancers2022

Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients.

Yan-Jei Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.